AAAAAA
Results: 1-25/30
Authors:
Sica, DA
Citation: Da. Sica, The Heart Outcomes Prevention Evaluation study: angiotensin-converting enzyme inhibitors: are their benefits a class effect or do individual agents differ?, CURR OP NEP, 10(5), 2001, pp. 597-601
Authors:
Sica, DA
Citation: Da. Sica, Improvement of clinical outcomes in hypertension: Advantages of angiotensin receptor blockers - Introduction, AM J HYPERT, 14(7), 2001, pp. 225S-225S
Authors:
Sica, DA
Citation: Da. Sica, Pharmacology and clinical efficacy of angiotensin receptor blockers, AM J HYPERT, 14(7), 2001, pp. 242S-247S
Authors:
Schoolwerth, AC
Sica, DA
Ballermann, BJ
Wilcox, CS
Citation: Ac. Schoolwerth et al., Renal considerations in angiotensin converting enzyme inhibitor therapy - A statement for healthcare professionals from the council on the kidney in cardiovascular disease and the council for high blood pressure research of the American Heart Association, CIRCULATION, 104(16), 2001, pp. 1985-1991
Authors:
Sica, DA
Citation: Da. Sica, Dosage considerations with perindopril for systemic hypertension, AM J CARD, 88(7A), 2001, pp. 13I-18I
Authors:
Sica, DA
Citation: Da. Sica, Hypertension and its treatment in concomitant conditions - Degenerative joint disease, depression, Alzheimer disease, and Parkinson disease, CUR CL PRAC, 2001, pp. 403-409
Authors:
Sica, DA
Wilson, DK
Citation: Da. Sica et Dk. Wilson, Sodium, potassium, the sympathetic nervous system, and the renin-angiotensin system - Impact on the circadian variability in blood pressure, CONTEMP CAR, 2001, pp. 171-189
Authors:
Sica, DA
Citation: Da. Sica, Endothelial cell function: new considerations, EUR H J SUP, 2(B), 2000, pp. B13-B21
Authors:
White, WB
Sica, DA
Citation: Wb. White et Da. Sica, Vascular disease and the renin-angiotensin system in the patient with hypertension - Foreword, BL PRESS M, 5, 2000, pp. S1-S1
Authors:
Sica, DA
Citation: Da. Sica, The importance of the sympathetic nervous system and systolic hypertensionin patients with hypertension: benefits in treating patients with increased cardiovascular risk, BL PRESS M, 5, 2000, pp. S19-S25
Authors:
Hollenberg, NK
Izzo, JL
Sica, DA
White, WB
Mansoor, GA
Citation: Nk. Hollenberg et al., Vascular disease and the renin-angiotensin system in the patient with hypertension: panel discussion and questions from the audience, BL PRESS M, 5, 2000, pp. S27-S29
Authors:
Sica, DA
Citation: Da. Sica, Class effects of angiotensin-converting enzyme inhibitors, AM J M CARE, 6(3), 2000, pp. S85-S108
Authors:
Ripley, E
King, K
Sica, DA
Citation: E. Ripley et al., Racial differences in response to acute dosing with hydrochlorothiazide, AM J HYPERT, 13(2), 2000, pp. 157-164
Authors:
Sica, DA
Halstenson, CE
Gehr, TWB
Keane, WF
Citation: Da. Sica et al., Pharmacokinetics and blood pressure response of losartan in end-stage renal disease, CLIN PHARMA, 38(6), 2000, pp. 519-526
Authors:
Bloomfield, GL
Sugerman, HJ
Blocher, CR
Gehr, TWB
Sica, DA
Citation: Gl. Bloomfield et al., Chronically increased intra-abdominal pressure produces systemic hypertension in dogs, INT J OBES, 24(7), 2000, pp. 819-824
Authors:
Wilson, DK
Kliewer, W
Plybon, L
Sica, DA
Citation: Dk. Wilson et al., Socioeconomic status and blood pressure reactivity in healthy black adolescents, HYPERTENSIO, 35(1), 2000, pp. 496-500
Authors:
Sica, DA
Gehr, TWB
Fernandez, A
Citation: Da. Sica et al., Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal disease, DRUG SAFETY, 22(5), 2000, pp. 350-360
Authors:
Pedro, AA
Gehr, TWB
Brophy, DF
Sica, DA
Citation: Aa. Pedro et al., The pharmacokinetics and pharmacodynamics of losartan in continuous ambulatory peritoneal dialysis, J CLIN PHAR, 40(4), 2000, pp. 389-395
Authors:
Sica, DA
Liao, WC
Gehr, TWB
Khan, S
Jemal, M
Delaney, CL
Ferreira, IM
Malhotra, BK
Citation: Da. Sica et al., Disposition and safety of omapatrilat in subjects with renal impairment, CLIN PHARM, 68(3), 2000, pp. 261-269
Authors:
Doty, JM
Saggi, BH
Sugerman, HJ
Blocher, CR
Pin, R
Fakhry, I
Gehr, TWB
Sica, DA
Citation: Jm. Doty et al., Effect of increased renal venous pressure on renal function, J TRAUMA, 47(6), 1999, pp. 1000-1003
Authors:
Sica, DA
Citation: Da. Sica, Impact of antihypertensive therapy on the rate-pressure product: the role of chronotherapeutics, EUR H J SUP, 1(B), 1999, pp. B24-B33
Authors:
Wilson, DK
Sica, DA
Miller, SB
Citation: Dk. Wilson et al., Ambulatory blood pressure nondipping status in salt-sensitive and salt-resistant black adolescents, AM J HYPERT, 12(2), 1999, pp. 159-165
Authors:
Wilson, DK
Kliewer, W
Bayer, L
Jones, D
Welleford, A
Heiney, M
Sica, DA
Citation: Dk. Wilson et al., The influence of gender and emotional versus instrumental support on cardiovascular reactivity in African-American adolescents, ANN BEHAV M, 21(3), 1999, pp. 235-243
Authors:
Sica, DA
Hollenberg, NK
Citation: Da. Sica et Nk. Hollenberg, The renal profile of eprosartan, PHARMACOTHE, 19(4), 1999, pp. 86S-94S
Authors:
Sica, DA
Citation: Da. Sica, Review of eprosartan: A new angiotensin II receptor antagonist - Summary, PHARMACOTHE, 19(4), 1999, pp. 108S-109S